BDO is one of the largest accounting firms in the Thames Valley providing a comprehensive range of accounting, tax, advisory and business services to clients across Berkshire, Buckinghamshire, Oxfordshire, North Hampshire and the surrounding area.
The experts and specialists in our Reading – Thames Tower office work with a wide range of ambitious organisations from fast growing businesses to large international companies, providing the ideas and insight gained from a strong local presence, as well as the depth and breadth of expertise and resources that can only be found at a leading global accountancy firm.
We have a second office in Reading located at: R+, 2nd Floor, 2 Blagrave Street, Reading RG1 1AZ.
Boyds is a global drug development consultancy helping to translate ideas into cutting-edge medicinal products and treatments for patient benefit. With offices in the UK, US and Europe, Boyds provides a wide range of specialised expertise and skills central to the development of medicinal products and medical devices.
Working with pharma companies, biotechs, spin-outs, medical device companies and academic institutions, the team at Boyds provides expert support at any stage of their drug development journey, across a range of therapeutic areas.
We also support investors and VCs by providing comprehensive and thorough scientific due diligence, expert analysis and advice on the technical, regulatory, and commercial aspects of drug development.
We bring extensive scientific and regulatory expertise to assess the feasibility and potential risks of a drug project, evaluate the quality of the scientific data, and provide recommendations on the best development strategy, helping clients to make informed investment decisions.
Pharmaron is a global R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 17,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners around the world. To learn more visit: www.pharmaron.com
www.pharmaron.com@company